Monday, April 7, 3:00 - 4:05 p.m. - Room Poulenc

Chemoprevention of Barrett's esophagus and complications

N.S. Buttar (USA)  -  X. Chen (USA)

How can protective role of H pylori against GERD and formation of Barrett's esophagus be specified? F. Pace (Milan)
What can be expected from "Triple therapy" as chemoprevention against dysplasia in Barrett's esophagus? S. Stowe (Mooresville)
What are the effects of selective and non-selective COX 2 inhibitors on the development of adenocarcinomas? P. Bechi (Florence)
Is it possible to trace the natural history of patients with adenocarcinoma diagnosed outside of a Barrett's surveillance program? G. Singh Segal (Palo Alto)

     

Monday, April 7, 5:25 - 6:30 p.m. - Room Poulenc

Diagnosis of radiographic esophageal strictures

C.L. Canon (USA)  - P. Pokieser (Vienna)
What is the compared sensitivity of barium examination and endoscopy as the first step for evaluating patients with dysphagia? R. Tutuian (Zurich)
How should stricture be diagnosed on imaging studies? M.S. Levine (Philadelphia)
What is the role of esophagography after dilalation? I. Laufer (Philadelphia)
Can a grading system for esophageal strictures be devised? A. Wuttge-Hannig (Munich)

     
Tuesday, April 8, 3:00 - 4:05 p.m. - Room Poulenc

Non Cardiac Chest Pain and irritable esophagus From physio-pathology to treatment

R.K. Mittal (USA)  -  J.E. Richter (USA)
Is two day-pH monitoring with wireless system a reliable indicator of GERD in patients with NCCP? Prakash Gyawali (St Louis)
Can MII / pH monitoring allow for a better evaluation of abnormal GER in patients with NCCP? A.J.P.M. Smout (Utrecht)
Is PPI test still to be recommended in patients with NCCP? J. Williams (Chicago)
Are there any effective surgical treatments for NCCP? V.N. Prachand (Chicago)

     


Tuesday, April 8, 5:25 - 6:30 p.m. - Room Poulenc

Management of PPI resistant GERD

C. Scarpignato (Italy) -  J.E. Pandolfino (USA)
What is the compared predictable response to PPI therapy in patients with NERD / erosive esophagitis? M. Cicala (Rome)
  - What is the value of intra-gastric pH as an indirect marker for the efficacy of PPI therapy?
What is the clinical value of MII /pH monitoring in patients with refractory GERD symptoms? F. Zerbib (Bordeaux)
Improvement of reflux parameters with Baclofen in GERD patients. R.K. Wong (Washington)
The interest of GABA B agonists in PPI resistant GERD patients  I.J.S. Cook  (Sydney)
The inhibitors of TLESRs A. Lehmann  (Gothenburg)

     


Wednesday, April 9, 3:00 - 4:05 p.m. - Room Poulenc

Prevention of aspiration in GERD

I.J.S. Cook (Australia)  -  R. Hunt (Canada)
The esophago-pharyngo-laryngeal protective reflexes
J. Allen / P. Belafsky (Los Angeles)

The mechanisms of esophago-pharyngeal regurgitation and aspiration R. Shaker (Milwaukee)
A non invasive diagnostic tool for detecting patients ar risk of aspiration in GERD P. Dettmar (Hull)
How to manage the patient with suspected GERD-related aspiration? S.M. Harding  (Birmingham, AL)
Is eating before bedtime a major factor in nocturnal pulmonary symptoms? S.J. Sontag  Chicago)

     


Wednesday, April 9, 5:25 - 6:30 p.m. - Room Poulenc

Developmental abnormalities of the esophagus

S.R. Jadcherla (USA)  -  E.H. Metman (France)
What are the consequences of esophageal atresia in adult life? E.H. Metman (Tours)
What are the mechanisms that cause and protect against GER in infants? S.R. Jadcherla (Columbus)
How is GERD different in infants vs older children? N. Tipnis (Milwaukee)
What is the relevance of pediatric GERD in adult life? G. de Angelis (Parma)